4
Changes in Ownership
Pelthos Therapeutics Inc. Filed Acc 0001919246-26-000052
Director sold 797 shares at an average $20.92 ($16,670)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Greenleaf Peter · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-02 | Sale : show line 1 in the form 10b5-1 | −420 | $20.52 | $8,616 | 25,058 | D |
| 2026-04-02 | Sale : show line 2 in the form 10b5-1 | −377 | $21.36 | $8,053 | 24,681 | D |
| Open-market sales · 797 sh · avg $20.92 · $16,670 | ||||||
Loading xslF345X06/wk-form4_1775509257.xml…